Harvard Bioscience Inc financial data

Symbol
HBIO on Nasdaq
Industry
Laboratory Analytical Instruments
Location
84 October Hill Rd, Holliston, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 148 % -29.9%
Quick Ratio 78.2 % -26.8%
Debt-to-equity 96.4 % +6.68%
Return On Equity -18.7 % -308%
Return On Assets -9.54 % -295%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 44.1M shares +1.49%
Common Stock, Shares, Outstanding 44.1M shares +1.57%
Entity Public Float 115M USD
Common Stock, Value, Issued 441K USD +1.61%
Weighted Average Number of Shares Outstanding, Basic 43.5M shares +2.64%
Weighted Average Number of Shares Outstanding, Diluted 43.5M shares +2.64%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 94.1M USD -16.1%
Research and Development Expense 10.4M USD -11.5%
Selling and Marketing Expense 22.2M USD -7.68%
General and Administrative Expense 21.5M USD -5.55%
Operating Income (Loss) -6.21M USD -428%
Nonoperating Income (Expense) -5.45M USD -22.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -11.7M USD -356%
Income Tax Expense (Benefit) 740K USD -13.9%
Net Income (Loss) Attributable to Parent -12.4M USD -263%
Earnings Per Share, Basic -0.28 USD/shares -250%
Earnings Per Share, Diluted -0.28 USD/shares -250%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.11M USD -4.09%
Accounts Receivable, after Allowance for Credit Loss, Current 14.9M USD -7.66%
Inventory, Net 23.2M USD -5.95%
Other Assets, Current 2.9M USD -26.4%
Assets, Current 45.1M USD -8%
Deferred Income Tax Assets, Net 92K USD -78.9%
Property, Plant and Equipment, Net 5.11M USD +28.3%
Operating Lease, Right-of-Use Asset 6.13M USD +28.5%
Intangible Assets, Net (Excluding Goodwill) 11.1M USD -30.6%
Goodwill 56.3M USD -1.3%
Other Assets, Noncurrent 2.83M USD -56.2%
Assets 127M USD -7.81%
Accounts Payable, Current 4.79M USD -13.8%
Employee-related Liabilities, Current 1.71M USD -56.4%
Contract with Customer, Liability, Current 3.81M USD -15.6%
Liabilities, Current 55M USD +107%
Deferred Income Tax Liabilities, Net 710K USD -8.51%
Operating Lease, Liability, Noncurrent 6.38M USD +33.1%
Other Liabilities, Noncurrent 1.26M USD -15%
Liabilities 63.3M USD -1.54%
Accumulated Other Comprehensive Income (Loss), Net of Tax -15.7M USD -10.4%
Retained Earnings (Accumulated Deficit) -158M USD -8.52%
Stockholders' Equity Attributable to Parent 63.3M USD -13.3%
Liabilities and Equity 127M USD -7.81%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.4M USD -22.6%
Net Cash Provided by (Used in) Financing Activities -1.06M USD +63.5%
Net Cash Provided by (Used in) Investing Activities -225K USD -178%
Common Stock, Shares Authorized 80M shares 0%
Common Stock, Shares, Issued 44.1M shares +1.57%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -28K USD +96.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 768K USD -34.5%
Deferred Tax Assets, Valuation Allowance 17.8M USD +16.7%
Deferred Tax Assets, Gross 23.7M USD +5.15%
Operating Lease, Liability 7.54M USD +21.4%
Depreciation 404K USD +21.3%
Payments to Acquire Property, Plant, and Equipment 645K USD +188%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -13.9M USD -444%
Lessee, Operating Lease, Liability, to be Paid 9.54M USD +16.5%
Property, Plant and Equipment, Gross 20.9M USD +13.9%
Operating Lease, Liability, Current 1.16M USD -18.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.81M USD -5.08%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.81M USD +229%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure -10.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2M USD +0.96%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.79M USD +54.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 1.99M USD -10.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.77M USD +68.6%
Operating Lease, Payments 597K USD -8.58%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 5.26M USD -4.89%
Deferred Tax Assets, Net of Valuation Allowance 5.9M USD -19.1%
Share-based Payment Arrangement, Expense 5M USD +13.4%